Pancreas transplantation for type I diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 1868-1874

  Robertson, R Paul ^a   Holohan, Thomas V ^c   Genuth, Saul ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HEMOGLOBIN A1C; IMMUNOSUPPRESSIVE AGENT; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; GLYCOSYLATED HEMOGLOBIN;

CLINICAL TRIAL; DIABETES CONTROL; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY TRANSPLANTATION; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; ARTICLE; BLOOD; METABOLISM; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0032088910     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.1868     Document Type: Review

References (26)

1. Sutherland DER, Gruessner RWG. 1997 Current status of pancreas transplantation for the treatment of type 1 diabetes mellitus. Clinical Diabetes. 15:152-156.
2. European IDDM Policy Group. 1993 Consensus guidelines for the management of insulin-dependent (type 1) diabetes. Diabetic Med. 10:990-1005.
3. American Diabetes Association. 1994 Standards of medical care for patients with diabetes mellitus. Diabetes Care. 17:616-623.
4. Robertson RP, Sutherland DE, Kendall DM, Teuscher AU, Gruessner RW, Gruessner A. 1996 Metabolic characterization of long-term successful pancreas transplants in type 1 diabetes. J Invest Med. 44:549-555.
5. Saudek F, Pelkanova T, Bartos V, et al. 1991 Insulin action and insulin binding following pancreas transplantation. Diabetologia. 34 (Suppl. 1):S71-S75.
6. Osei K, Cottrell DA, Henry ML, Tesi RJ, Ferguson RM, O'Dorisio TM. 1992 Insulin insensitivity and glucose effectiveness in type 1 diabetic allograft pancreas recipients. Trans Proc. 24:828-830.
7. Cottrell Daryl A. 1996 Normalization of insulin sensitivity and glucose homeostasis in type 1 diabetic pancreas transplant recipients: A 48-month cross-sectional study - a clinical research center study. J Clin Endocrinol Metab. 81:3513-3519.
8. Christiansen E, Tibell A, Volund AA, et al. 1997 Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab. 82:2299-2307.
9. Rooney DP, Robertson RP. 1996 Hepatic insulin resistance after pancreas transplantation in type 1 diabetes. Diabetes. 45:134-138.
10. The Diabetes Control and Complications Trial Research Group. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:977-986.
11. The Diabetes Control and Complications Trial Research Group. 1995 Progression of retinopathy with intensive vs. conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology. 102:647-661.
12. Leone JP, Humar A, Gruessner RWG, Sutherland DER. 1997 Pancreas transplantation: Indications, clinical management, and outcomes. Front Biosci. 2,e34-40.
13. Deckert T, Poulsen JE, Larsen M. 1978 Prognosis of diabetics with diabetes onset before the age of thirty-one (Survival, causes of death, and complications). Diabetologia. 14:363-370.
14. Hickey DP, Bakthavatsalam R, Bannon CA, O'Malley K, Corr J, Little DM. 1997 Urological complications of pancreatic transplantation. J Urol. 157:2042-2048.
15. Sindhi R, Stratta RJ, Lowell JA, et al. 1997 Experience with enteric conversion after pancreatic transplantation with bladder drainage. J Am Coll Surg. 184:281-289.
16. Calafiore R. 1997 Perspectives in pancreatic and islet cell transplantation for the therapy of IDDM. Diabetes Care. 20:889-896.
17. Smets YF, van der Pijl JW, vanDissel JT, Ringers J, de Fijter JW, Lemkes HH. 1997 Infectious disease complications of simultaneous pancreas kidney transplantation. Nephrol Dial Transplant. 12:764-771.
18. Benedetti E, Gruessner AC, Troppmann C, et al. 1996 Intra-abdominal fungal infections after pancreatic transplantation: Incidence, treatment, and outcome. J Am Coll Surg. 183:307-316.
19. Kimball P, Ham J, Eisenberg M, et al. 1997 Lethal graft-versus-host disease after simultaneous kidney-pancreas transplantation. Transplantation. 63:1685-1688.
20. Martinenghi S, Dell'Antonio G, Secchi A, DiCarlo V, Pozza G. 1997 Cancer arising after pancreas and/or kidney transplantation in a series of 99 diabetic patients. Diabetes Care. 20:272-275.
21. Stratta RJ, Weide LG, Sindhi R, et al. 1997 Solitary pancreas transplantation: Experience with 62 consecutive cases. Diabetes Care. 20:362-368.
22. Stratta RJ, Taylor RJ, Sindhi R, Sudan D, Jerius JT, Gill IS. 1996 Analysis of early readmissions after combined pancreas-kidney transplantation. Am J Kidney Dis. 28:867-877.
23. The Diabetes Control and Complications Trial Research Group. 1995 The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 44:968-983.
24. Barnett HJ, Peerless SJ, Fox AJ, et al. 1985 Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomised trial. Report of the ED/IC Bypass Study Group. N Engl J Med. 313:1191-1200.
25. Sundt Jr TM. 1987 Was the international randomized trial of extracranial-intracranial arterial bypass representative of the population at risk? N Engl J Med. 316:814-816.
26. Goldring S, Zervas N, Langfitt T. 1987 The extracranial-intracranial bypass study: a report of the committee appointed by the American Association of Neurological Surgeons to examine the study. N Engl J Med. 316:817-820.